The information published on this website is intended for healthcare professionals, regulatory authorities and export distributors. It is not designed as patient-facing prescribing information or as a substitute for professional medical advice.
Schedule H Notice #
Use of Information #
While Taj Pharma takes reasonable care to keep technical and regulatory content accurate, official prescribing information for any market is governed by the registration approved by the relevant national health authority. In the event of any discrepancy, the locally approved Summary of Product Characteristics shall prevail.
No Direct Patient Advice #
Patients must consult a qualified physician or pharmacist for individualised advice on therapy.
Pack Size Statement #
Not all pack sizes or strengths described on this website may be marketed in every territory. Availability is subject to local registration and supply agreements.
Pharmacovigilance #
Suspected adverse drug reactions associated with Taj Pharma products should be reported to pharmacovigilance@tajpharma.com or to the relevant national pharmacovigilance authority.